Model
Edge
Lineage Cell Therapeutics
0001310683
Filing Type
4
Filing Date
11/21/2024
Updated
11/22/24, 7:00 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership